Fred Hutch graduate student Adam Nguyen has won a F31 training award from the NIH to study a complex molecule called Tie2 ...

The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic ...

Accuray Incorporated ARAY recently revealed findings from an international multicenter analysis, showing that the CyberKnife ...

Accuray (ARAY) announced international retrospective multicenter analysis found that radiosurgery, or SRS, and fractionated ...

A live webcast will be available in the Investors section of the company's website at , and archived for 30 days following the presentation.

The FDA approved ensartinib (Ensacove) as a first-line treatment for adults with ALK -positive locally advanced or metastatic ...

Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...

The FastGlioma tool could enable rapid and accurate detection of microscopic tumour infiltration, improving the success of ...

The addition of atezolizumab to neoadjuvant chemotherapy failed to significantly improve event-free survival in patients with ...

Upon suspension of the trading of its Common Stock on Nasdaq, the Company expects that its Common Stock will be quoted under its existing symbol “VCNX” on the OTC Markets Group. About Vaccinex, Inc.

Dr Michelle Melisko discusses the challenging aspects involved in decision-making around screening for brain metastasis in ...

Cancer is one of the most formidable health challenges of our time, affecting nearly half of us during our lives. While treatments have significantly improved in recent decades, the biggest challenge ...